Find a trial

POPSTAR II

Lu-PSMA for Oligometastatic Prostate Cancer Treated With Stereotactic Ablative Radiotherapy

Locations Epworth Richmond, Epworth Freemasons, Moreland, Holmesglen, Mulgrave

Diagnosis Prostate cancer

rechARge / CA071-1000

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Locations Hobart, Adelaide

Diagnosis Prostate cancer

78278343PCR1003

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer

Locations Adelaide

Diagnosis Prostate cancer

WOMBAT / ANZUP 2201

Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide

Locations Chermside

Diagnosis Prostate cancer

TUTELA / TUT-001A

To evaluate the feasibility of inserting Tutelix™ to reduce the dose of radiation to the rectum in men undergoing radiotherapy

Locations Gold Coast University Hospital

Diagnosis Prostate cancer

MEVPRO-1 / C2321014

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer

Locations Wesley

Diagnosis Prostate cancer